SARS-CoV-2 Genome Sequence Obtained from Ethiopia.

Autor: Bitew M; Ethiopia Biotechnology Institute (EBTI), Addis Ababa, Ethiopia., Hailu G; Addis Ababa University, Aklilu Lemma Institute of Pathobiology (ALPB), Addis Ababa, Ethiopia., Gebregziabher Tsegay Y; Department of Medical Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia., Tuki K; Ethiopia Biotechnology Institute (EBTI), Addis Ababa, Ethiopia., Asmamaw K; Ethiopia Biotechnology Institute (EBTI), Addis Ababa, Ethiopia., Tesfaye K; Ethiopia Biotechnology Institute (EBTI), Addis Ababa, Ethiopia., Dadi H; Ethiopia Biotechnology Institute (EBTI), Addis Ababa, Ethiopia., Orsini E; Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Dal Monego S; AREA Science Park Padriciano, Trieste, Italy., Licastro D; AREA Science Park Padriciano, Trieste, Italy., Marcello A; Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Jazyk: angličtina
Zdroj: Microbiology resource announcements [Microbiol Resour Announc] 2022 Feb 17; Vol. 11 (2), pp. e0118221. Date of Electronic Publication: 2022 Feb 03.
DOI: 10.1128/mra.01182-21
Abstrakt: The coding-complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome sequences from 15 nasopharyngeal swabs collected in Addis Ababa, Ethiopia, during the period from December 2020 to March 2021 were determined using Illumina MiSeq technology. A sequence analysis identified that the B.1 SARS-CoV-2 lineage was most prevalent with the worrying emergence of B.1.1.7 in June 2021.
Databáze: MEDLINE